Is platinum the new gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapies

Platinum (Pt)-based chemotherapy has served for decades as the foundation of ovarian cancer therapy. Yet, its gains are always undermined by severe toxic side effects and drug resistance. Although a new generation of therapy — including anti-angiogenic drugs, PARP inhibitors, ADCs, and immune checkp